Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additional ultrasonic findings (vascularisation, myometrial invasion, and inhomogeneity) improves diagnostic accuracy. Materials and Methods: In a prospective study the authors included 447 postmenopausal patients, treated for endometrial pathology. Ultrasound assessment was followed by endometrial sampling and histopathological examination. Results were compared according to presence of symptoms and histopathological findings (benign and malignant). Results: Eighty-six percent (385) patients were symptomatic and 14% (62) were asymptomatic. In the symptomatic patients with ET ≥ 5 mm, 17.5% had EC (CI: 13.5 -22); there was no patient with EC and ET less than 5 mm (CI: 0-15). All asymptomatic patients with ET ≥ 11 mm had benign findings. Three asymptomatic patients with malignancy were discovered because of other suspicious findings than ultrasound. Additional ultrasonic assessment showed statistically relevant results in symptomatic group (p < 0.05). Conclusions: In symptomatic women, less than 5 mm ET threshold rules out patients with EC with good certainty. In asymptomatic patients, ET measurement played no role in discovering EC.
Authors and Affiliations
K. Jakopič Maček, Š. Bricl, I. Verdenik, B. Kobal
The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites
Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared...
Immunohistochemical analysis of IQGAP2 in ovarian cancer
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immuno...
Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...
Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines
Purpose of Investigation: Patients suffering from ovarian cancer often use mistletoe preparations in combination with Taraxacum officinale (dandelion) extracts as supplementary therapy to conventional medicine. However,...
Complementary and alternative medicine. Use and challenges among gynaecological cancer patients in Nigeria: experiences in a tertiary health institution - preliminary results
Background: Cancer patients have keyed into increasing global interest in the use of Complementary and Alternative Medicine (CAM). There are few studies on CAM use among gynaecological cancer patients in our environment....